Skip to main content

Find Clinical Trials

Home
Conditions
Empagliflozin

Clinical trial condition

Empagliflozin

Explore clinical trials studying Empagliflozin. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Empagliflozin trial results

Recruiting

DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis

NCT07322237

Conditions: Ascites, Cardiometabolic Risk Factors, Cardiovascular Diseases, +9 more
Locations: PGIMER Chandigarh Chandigarh, India

View Trial Details

Completed

Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)

NCT05013112

Conditions: Empagliflozin, Kidney Transplantation, Metabolic Diseases, +3 more
Locations: West china hospital Chengdu, Sichuan, China

View Trial Details

Completed

Antidiabetic Drugs for Steatotic Liver Disease

NCT03646292

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Disease, +19 more
Locations: Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea Seoul, South Korea

View Trial Details

Completed

Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient

NCT06145360

Conditions: Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +13 more
Locations: SINA Shireen Jinnah colony Karachi, Pakistan

View Trial Details

Active, Not Recruiting

Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients

NCT05147090

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +24 more
Locations: The University of Hong Kong/Queen Mary Hospital Hong Kong, Hong Kong, China

View Trial Details